VIX
38
-8
VLO
30
2
PDCO
46
3
TXN
42
2
TJX
50
2
HCP
47
-2
AMT
56
-3
GD
60
3
PFE
32
4
DTE
67
2
AAPL
46
-2
UA
59
3
HAL
50
2
HRL
30
3
FIS
55
2
CMI
54
3
EQT
45
6
REGN
53
-3
PCG
85
2
WEC
51
6
VIX
38
-8
VLO
30
2
PDCO
46
3
TXN
42
2
TJX
50
2
HCP
47
-2
AMT
56
-3
GD
60
3
PFE
32
4
DTE
67
2
AAPL
46
-2
UA
59
3
HAL
50
2
HRL
30
3
FIS
55
2
CMI
54
3
EQT
45
6
REGN
53
-3
PCG
85
2
WEC
51
6
Financhill
Back

ProShares Ultra Communication Services Vs. Kymera Therapeutics Industry Stock Comparison

Buy
62

LTL
ProShares Ultra Communication Services

Last Price:
74.93
Seasonality Move:
6.47%
Buy
71

KYMR
Kymera Therapeutics

Last Price:
47.11
Seasonality Move:
65.72%
Buy
62
ProShares Ultra Communication Services (LTL) is a Buy

Is ProShares Ultra Communication Services a Buy, Sell or Hold?

  • The current ProShares Ultra Communication Services [LTL] share price is $74.87. The Score for LTL is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • LTL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

LTL Stock Price Chart

What is ProShares Ultra Communication Services's stock price today?

  • The ProShares Ultra Communication Services share price today is $74.87
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LTL is experiencing buying pressure, which is a positive indicator for future bullish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $49.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

LTL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.47 Buy
Relative Strength Index (14 RSI): 62.51 Buy
Chaikin Money Flow: 547 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (70.4 - 74.66) Buy
Bollinger Bands (100): (64.9 - 71.52) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 59.12 Buy
Chaikin Money Flow: 317205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.81 - 49.49) Buy
Bollinger Bands (100): (34.86 - 47.92) Buy

LTL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 74.1 Buy
20-day SMA: 73.44 Buy
50-day SMA: 69.82 Buy
200-day SMA: 63.75 Buy
8-day EMA: 74.29 Buy
20-day EMA: 73.05 Buy
50-day EMA: 70.66 Buy
200-day EMA: 63.31 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.58 Buy
20-day SMA: 46.67 Buy
50-day SMA: 46.11 Buy
200-day SMA: 38.62 Buy
8-day EMA: 45.67 Buy
20-day EMA: 45.85 Buy
50-day EMA: 45.2 Buy
200-day EMA: 38.5 Buy

ProShares Ultra Communication Services Earnings Growth & LTL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

ProShares Ultra Communication Services Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):